Precipio inc.

Products Division revenues begin to diversify beyond HemeScreen®NEW HAVEN, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) delivered ...Precipio Inc. First, up the list, Precipio is red hot in the stock market now. The company is launching its rapid COVID-19 antibody test for sale on the world’s biggest e-commerce Amazon ...NEW HAVEN, Conn., Aug. 01, 2023 -- Specialty cancer diagnostics company Precipio, Inc. , announces that Q2-2023 revenues have increased to $3.5M in Q2-2023 from $2.8M in Q1-2023, an increase of 25%...Jan 13, 2020 · NEW HAVEN, Conn., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that on Monday, January 20th at 5pm it will conduct a shareholder ... Precipio EPS beats by $0.08, misses on revenue. Get the latest news and real-time alerts from Precipio, Inc. (PRPO) stock at Seeking Alpha.

0001558370-22-017400.txt : 20221110 0001558370-22-017400.hdr.sgml : 20221110 20221110160240 ACCESSION NUMBER: 0001558370-22-017400 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT(Bloomberg) -- Chinese stocks slid following a much-anticipated meeting between Presidents Joe Biden and Xi Jinping, as traders saw only modest progress in …

Precipio, Inc., and Subsidiary, (“we”, “us”, “our”, the “Company” or “Precipio”) is a cancer diagnostics company providing diagnostic products and services to the oncology market. We have built and continue to develop a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and ...

Private Placement . On the Closing Date and in connection with the Merger, New Precipio issued 107,056 shares of New Preferred Stock (the “Private Placement Shares”) at a price of $3.736329 per share to certain investors in exchange for $400,000 pursuant to a Securities Purchase Agreement (the “Private Placement Purchase Agreement”) between New …Preparing a financial plan for your business is important if you plan to pursue business finance options such as loans, according to Inc. Business finance companies look at the short-term viability as well as the long-term potential of a bu...Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and ... PRPO, the stock of Precipio Inc, has shown promising performances on September 28, 2023, according to data from CNN Money. The stock has garnered significant attention from analysts, with a median target price of $40.00. This represents a substantial increase of 587.29% from the last recorded price of $5.82.On March 26, 2020, Precipio. Inc. (“we” or the “Company”) entered into a purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”) pursuant to which Lincoln Park has agreed to purchase from us, from time to time, up to …

View the latest Precipio Inc. (PRPO) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality ...

Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality ...About Precipio. Precipio Inc. is a healthcare company focused on cancer diagnostics. The Company’s mission is to address the pervasive problem of cancer misdiagnosis by developing products to ...A. Zaki Sabet has been with Precipio since co-founding the company in 2011 and currently serves as the Chief Operating Officer. He holds over 12 years of experience in laboratory management spanning all fields of reference laboratory operations primarily focusing on cancer diagnostics. Prior to Precipio, Zaki has served as a consultant with the ... Proprietary Technologies. Precipio has developed several cutting-edge technologies to provide unparalleled diagnostic accuracy. These technologies help address issues from low cellularity, false negatives in …NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched the HemeScreen ® Anemia Panel as part of its suite ...PRECIPIO INC's upside potential (average analyst target price relative to current price) is greater than 5.37% of Healthcare stocks. PRPO has a higher average analyst price target than 7.27% of Measuring and Control Equipment stocks.

About Precipio. Precipio Inc. is a healthcare company focused on cancer diagnostics. The Company’s mission is to address the pervasive problem of cancer misdiagnosis by developing products to ...As previously reported on October 13, 2016, Transgenomic, Inc. (the “Company”), New Haven Labs Inc., a wholly-owned subsidiary of the Company, and Precipio Diagnostics, LLC (“Precipio”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which Precipio will become a wholly-owned subsidiary of the Company (the …NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it continues to receive both new and repeat business from ...A high-level overview of Precipio, Inc. (PRPO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.C/O PRECIPIO, INC. 4 SCIENCE PARK (Street) NEW HAVEN: CT: 06511 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Precipio, Inc. [ PRPO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below)FORM 8-K. CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 6, 2023 PRECIPIO, INC.NEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO) today announced that it has implemented a 1-for-20 reverse stock split of ...

Co-Founder & COO at Precipio, Inc. (NASDAQ: PRPO) New Haven, CT. Connect Mark Rimer New York, NY. Connect Ayman Mohamad Chief Technology Officer at Precipio, Inc ...Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.

Precipio expects the project to be completed by the end of Q1 2020. On December 17th, Precipio announced the receipt of their first commercial order for IV-Cell from Northwell Health. Precipio estimates generating considerable six-figures in annual revenues to the company as the first midsize customer to adopt IV-Cell.On April 23, 2020, Precipio, Inc. (the “Company”) entered into a promissory note (the “Promissory Note”) evidencing an unsecured $787,200 loan under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (or “PPP”) was established under the recently congressionally-approved Coronavirus Aid, Relief, and ...On June 14, 2021, each of Ilan Danieli, Chief Executive Officer of Precipio, Inc. (the “Company”), and Mr. David Cohen, a director of the Company, adopted a Rule 10b5-1 stock trading plan (each a “Plan”, and together the "Plans"). The Plans were adopted in accordance with guidelines specified by Rule 10b5-1 under the Securities Exchange ...Precipio’s platform delivers superior diagnostic accuracy through specialized expertise and cutting edge technology. We are a laboratory focused on delivering superior hematology diagnostic services to physicians and their patients to ensure they receive accurate results. Get the latest Precipio, Inc. (PRPO) stock news and headlines to help you in your trading and investing decisions.Precipio, Inc. (NASDAQ:PRPO) Q2 2022 Earnings Conference Call August 15, 2022 5:00 PM ET. Company Participants. Ilan Danieli - Founder, President, CEO & Director. Conference Call Participants.Crede claims that Precipio has breached a Securities Purchase Agreement and Warrant that Crede entered into in connection with an investment in Transgenomic, Inc., the predecessor of the Company and that pursuant to those agreements, Precipio currently owes Crede the sum of $2,205,008.00. In addition to the aforementioned sum, Crede is …C/O PRECIPIO, INC. 4 SCIENCE PARK (Street) NEW HAVEN: CT: 06511 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Precipio, Inc. [ PRPO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: X: Officer (give title below)

Item 7.01 Regulation FD Disclosure . On March 18, 2021, Precipio, Inc (the "Company") announced that management will host a Q4-2020 and year-end Shareholder Update Call on Wednesday, March 31 st, 2021 at 5:00 PM EST.A copy of the letter is attached hereto as Exhibit 99.1 and incorporated herein by reference.

PRPO Growth Metrics. The 2 year net cashflow from operations growth rate now stands at 13.89%. ... Over the past 67 months, PRPO's revenue has gone up $7,477,000.

NEW HAVEN, Conn., April 27, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announces notification by the NASDAQ Stock Market that the Company has ...Precipio, Inc. (NASDAQ:PRPO) Q3 2021 Earnings Conference Call November 15, 2021 5:00 PM ETCompany Participants. Ilan Danieli - CEO. Conference Call Participants. Operator. Welcome to the Precipio ...Precipio, Inc. Attention: Ilan Danieli. 4 Science Park. New Haven, CT 06511 . Dear Mr. Danieli, The purpose of this letter (this “Agreement”) is to confirm the engagement of Euro Pacific Capital, Inc., doing business as A.G.P./Alliance Global Partners (“A.G.P.”) ...[relinking] Home Product Place Promotion Price Precipio, Inc. (PRPO) reported a revenue of $3.5 million in the first quarter of 2022. The company's net income for the same period was $-3.2 million. In terms of product, Precipio offers diagnostic products and services for oncology and COVID-19 testing. As of 2022, Precipio's stock price is $3.45 per share. …Co-Founder & COO at Precipio, Inc. (NASDAQ: PRPO) New Haven, CT. Connect Mark Rimer New York, NY. Connect Ayman Mohamad Chief Technology Officer at Precipio, Inc ...Mar 28, 2023 · Conference Call to be held on Monday, April 3rd, 2023 at 5:00 PM ETNEW HAVEN, Conn., March 28, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be ... Precipio, Inc. (PRPO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 7.00 -0.22 (-3.05%) At close: 03:20PM EST 6.74 +0.01 (+0.15%) After hours: 04:09PM EST Summary Company...Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality ...Precipio’s IV-Cell ® culturing media is a critical reagent intended to be used by cytogenetics laboratories to simplify, speed up and provide greater accuracy of their hematologic (blood cancer ...Precipio, Inc. | 2,193 followers on LinkedIn. Precipio’s vision is to battle the problem of cancer misdiagnosis by creating innovative diagnostic products. | Since its inception in 2011 ... ments (CLIA)-certified Precipio laboratory in New Haven, CT, and 982 samples were ultimately found to be suitable for testing. DNA was extracted using a QIAamp DNA Blood Mini Kit on a QIAcube automated system (QIAGEN, Hilden, Germany, cat. 51104) according to the manufacturer’s instructions and diluted with Tris- EDTA buffer to 10 ng/µL.C/O PRECIPIO, INC. 4 SCIENCE PARK (Street) NEW HAVEN: CT: 06511 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Precipio, Inc. [ PRPO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: X: Officer (give title below)

C/O PRECIPIO, INC. 4 SCIENCE PARK (Street) NEW HAVEN: CT: 06511 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Precipio, Inc. [ PRPO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: X: Officer (give title below)Aug 13, 2023 · August 13, 2023 at 10:16 AM · 3 min read. It's not a stretch to say that Precipio, Inc.'s ( NASDAQ:PRPO) price-to-sales (or "P/S") ratio of 0.9x right now seems quite "middle-of-the-road" for ... Precipio, Inc. NEW HAVEN, Conn., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces its Pathology Division has in August exceeded the ...NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it has entered into securities purchase agreements with ...Instagram:https://instagram. best gold buying sitesmega cap companiesapple dividend yielddalle 3 ai Precipio, Inc. (NASDAQ:NASDAQ:PRPO) Q3 2023 Earnings Conference Call November 20, 2023 5:00 PM ETCompany ParticipantsIlan Danieli - Chief Executive... all online banking appcollectable quarters list Dec 1, 2023 · Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering ... Elimination of Old Preferred Stock . On the Closing Date, New Precipio filed a certificate (the “Certificate of Elimination”) pursuant to Sections 103 and 151(g) of the Delaware General Corporation Law (the “DGCL”) eliminating from New Precipio’s Certificate of Incorporation the matters set forth in the Certificates of Designation for the Series A … caltier realty fund PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware : 91-1789357 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 4 Science Park, New Haven, CT : 06511 (Address of …As previously disclosed, on March 12, 2018, Precipio, Inc., a Delaware corporation (the “Company”) entered into a settlement agreement (the “Agreement”) with Crede Capital Group LLC (“Crede”) pursuant to which Precipio agreed to pay to Crede the total sum of $1.925 million (the “Settlement Amount”) payable in a combination of cash and stock in …